Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project
NCT05350735 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2022-04-28
Summary
Every year, rabies, a disease transmitted to humans by rabid dogs, is estimated to kill 59,000 people globally, mostly children 15 years and below in Africa and Asia. This is despite the availability of effective vaccines against rabies in humans, and in dogs. Following a dog bite, there are two critical steps required to prevent clinical disease and death: thorough wound washing with clean running water for at least 15 minutes; and immediate injection with anti-rabies vaccine on the day of being bitten followed by other four injections over the course of one month. Delay in seeking first dose of anti-rabies or failure to complete the recommended dosage may result in clinical rabies and death. The investigators proposed to assess the effect of short message system (SMS) phone text reminders sent to bite patients ahead of their scheduled visits on the adherence to scheduled anti-rabies doses among bite patients in rural eastern Kenya. The investigators enrolled bite patients presenting at Makueni County Referral Hospital between October 2018 and March 2019. Bite patients presenting to the facility between January and March 2019 received SMS reminder written in both English and local dialect a day before each dose of anti-rabies vaccine. These data were compared to those presenting to the health facility in the period prior (October to December 2018) before the introduction of the SMS reminder. This group received routine hospital cards as reminder of their next dose of anti-rabies vaccine injection. Each study participant was contacted after one month from the time of the bite and a phone interview completed to assess compliance and factors associated with completion of the five doses of anti-rabies vaccine.
Conditions
- Rabies
Interventions
- BEHAVIORAL
-
Intervention arm: SMS text reminders and medical card
This study arm will assess compliance with anti-rabies vaccine regimen by participants in the presence of SMS text reminders as compared to without the SMS reminder.
Sponsors & Collaborators
-
Washington State University
lead OTHER
Principal Investigators
-
Thumbi Mwangi, PhD · Washington State University, Paul G Allen School for Global Animal Health
-
Veronicah M Chuchu, PhD(c) · Washington State University - Global Health Kenya
-
Mutono Nyamai, PhD(c) · Washington State University - Global Health Kenya
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2019-08-01
- Completion
- 2019-08-01
Countries
- Kenya
Study Locations
More Related Trials
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
NCT06056050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT )
NCT05870631 ·Status: UNKNOWN ·Phase: PHASE4
-
Understanding Typhoid Disease After Vaccination
NCT01405521 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
NCT07347938 ·Status: NOT_YET_RECRUITING
-
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
NCT02813486 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3
-
Traveler's Diarrhea (TD) Automated Process
NCT00751777 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
NCT04099303 ·Status: COMPLETED ·Phase: PHASE1
-
Tunatar da ni. The Immunization Reminder and Information SMS System (IRISS)
NCT04001322 ·Status: COMPLETED ·Phase: NA
-
A School Health Center Intervention to Increase Adolescent Vaccination
NCT01595542 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Reminders to Complete HPV Series
NCT01731496 ·Status: COMPLETED ·Phase: NA
-
A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05
NCT05387083 ·Status: COMPLETED ·Phase: PHASE2
-
Immunization Schedule Alert Platform
NCT03705455 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888 ·Status: COMPLETED ·Phase: NA
-
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
NCT07112144 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
NCT07149454 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
NCT00870350 ·Status: UNKNOWN ·Phase: PHASE4
-
Tdap Vaccine Safety for Plasma Donors
NCT04142983 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation
NCT06360250 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
NCT02587520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Buzzy® and ShotBlocker® on Pain, Anxiety and Satisfaction During the Administration of Vaccine
NCT06397352 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tdap Vaccination for Infant Caregivers
NCT01233401 ·Status: COMPLETED